Search by Drug Name or NDC

    NDC 13845-1202-02 Cycloserine 250 mg/1 Details

    Cycloserine 250 mg/1

    Cycloserine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Parsolex Gmp Center, Inc.. The primary component is CYCLOSERINE.

    Product Information

    NDC 13845-1202
    Product ID 13845-1202_f2a0bd2c-bd4a-37f0-e053-2995a90a3c85
    Associated GPIs 09000030000105
    GCN Sequence Number 009319
    GCN Sequence Number Description cycloserine CAPSULE 250 MG ORAL
    HIC3 W1G
    HIC3 Description ANTITUBERCULAR ANTIBIOTICS
    GCN 41250
    HICL Sequence Number 004038
    HICL Sequence Number Description CYCLOSERINE
    Brand/Generic Generic
    Proprietary Name Cycloserine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Cycloserine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name CYCLOSERINE
    Labeler Name Parsolex Gmp Center, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA060593
    Listing Certified Through 2024-12-31

    Package

    NDC 13845-1202-02 (13845120202)

    NDC Package Code 13845-1202-2
    Billing NDC 13845120202
    Package 3 BLISTER PACK in 1 CARTON (13845-1202-2) / 10 CAPSULE in 1 BLISTER PACK
    Marketing Start Date 2013-09-12
    NDC Exclude Flag N
    Pricing Information N/A